The high price of cancer drugs in the US relative to European countries with universal health care raises ethical issues of access, financial burden on patients, and unsustainability of the health care system.
AMA J Ethics. 2015;17(8):750-753. doi:
10.1001/journalofethics.2015.17.8.nlit1-1508.
A survey suggests that there is broad consensus among physicians about the importance of honesty with patients, but there is variation in physicians' behavior in disclosing certain information to patients.